Viatris (NASDAQ: VTRS)
Viatris Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Viatris Company Info
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
News & Analysis
Viatris Tops Analyst Estimates in Q3
Viatris delivered a mixed quarter, topping earnings expectations but falling short on GAAP net income.
3 Top Value Stocks to Buy Right Now
Value stocks offer potential for significant returns in today's overheated market.
Why Viatris Stock Is Jumping Today
Investors are applauding the healthcare company's improving growth story.
Viatris Reports Mixed Q2 Results
Viatris reported mixed second-quarter 2024 results, with a net loss contrasting new product growth and strategic divestitures.
Is Viatris a Great Dividend Stock or Just a Value Trap?
Investors can collect a high yield with Viatris, but is it a risky payout to rely on?
Viatris Just Sold Off 3 Key Segments. Is It Still a Buy?
There's a chance shareholders won't notice any difference.
Could Viatris Stock Help You Become a Millionaire?
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks
These stocks offer some mouth-watering payouts.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.